Streetbeat News

Analyst Ratings

BBWI

Telsey Advisory Group analyst Dana Telsey maintains an Outperform rating on Bath & Body Works, Inc. (NYSE:BBWI) with a price target of $50, ahead of their Q4 earnings report. Sales are expected to decline 1.9% YOY to $2.833 billion, with a same-store sales decline of 5%. However, gross margin is projected to improve by over 100 bps to 44.4%, driven by merchandise margin improvement and cost optimization. Operating margin is expected to be 22.6%, slightly below market expectations. The company is also on track to generate $200 million in annual cost savings from its profit improvement plan.

Portfolio Pulse from Nabaparna Bhattacharya

February 22, 2024 | 7:36 pm

WDAY

Keybanc analyst Jason Celino maintains an Overweight rating on Workday (WDAY) and raises the price target from $310 to $330.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 7:36 pm

NVDA

Keybanc analyst John Vinh has maintained an Overweight rating on NVIDIA (NASDAQ:NVDA) and increased the price target from $740 to $1100, indicating a positive outlook on the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 7:34 pm

FIVN

Keybanc analyst Thomas Blakey maintains an Overweight rating on Five9 (NASDAQ:FIVN) but lowers the price target from $93 to $86.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 7:31 pm

ADSK

Keybanc analyst Jason Celino has maintained an Overweight rating on Autodesk (NASDAQ:ADSK) and increased the price target from $265 to $275. This adjustment reflects a positive outlook on the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 7:29 pm

COF

DFS

Discover Financial Services (DFS) was downgraded by RBC Capital Markets analyst Jon G. Arfstrom to Sector Perform from Outperform with a new price target of $140, following a merger deal with Capital One Financial Corp (COF). The deal offers Discover shareholders a 26.6% premium, with 1.0192 shares of COF for each DFS share. The merger is expected to be over 15% accretive to adjusted non-GAAP EPS and generate $2.7 billion in pre-tax synergies by 2027. The analyst sees the merger as compelling, despite past challenges faced by Discover, including compliance issues and leadership transitions.

Portfolio Pulse from Lekha Gupta

February 22, 2024 | 7:28 pm

NVCR

HC Wainwright & Co. analyst Emily Bodnar maintains a Buy rating on NovoCure (NASDAQ:NVCR) and raises the price target from $21 to $22.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 7:24 pm

BMY

Bristol-Myers Squibb (NYSE:BMY) has seen significant options market activity, with a bearish sentiment prevailing among big-money investors. Benzinga's options scanner revealed 9 unusual trades, with a split sentiment of 33% bullish and 66% bearish. The trades suggest a target price range of $40.0 to $62.5. The company, a leader in immuno-oncology, derives 70% of its sales from the U.S. Recent trading volume was 5,829,565, with a slight price decrease of -0.41%, and an RSI indicating potential overbought status. Analyst ratings in the last month have set an average target price of $52.5.

Portfolio Pulse from Benzinga Insights

February 22, 2024 | 7:16 pm

NVDA

Argus Research analyst Jim Kelleher has maintained a Buy rating on NVIDIA (NASDAQ:NVDA) and increased the price target from $600 to $850.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 7:14 pm

CAKE

Analyst ratings for Cheesecake Factory (NASDAQ:CAKE) show a mix of opinions, with recent updates indicating a shift towards a more positive outlook. The average 12-month price target has increased to $35.75, up from $32.50, with analysts from Piper Sandler, Barclays, Wedbush, and JP Morgan adjusting their ratings and price targets. Cheesecake Factory's financial performance is highlighted by a revenue growth rate of 5.89%, a net margin of 2.16%, an ROE of 5.54%, and an ROA of 0.65%, despite a high debt-to-equity ratio of 5.79.

Portfolio Pulse from Benzinga Insights

February 22, 2024 | 7:00 pm